Galectin Therapeutics Inc. (GALT)

NASDAQ: GALT · Real-Time Price · USD

4.610

+0.260 (5.98%)

At close: Sep 4, 2026, 4:00 PM EDT

4.690

+0.080 (1.74%)

After-hours: Sep 4, 2026, 7:58 PM EDT

Galectin Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	13.27	17.72	15.12	25.66	18.59	39.65
Cash & Short-Term Investments	13.27	17.72	15.12	25.66	18.59	39.65
Cash Growth	-3.65%	17.20%	-41.08%	38.02%	-53.11%	46.08%
Prepaid Expenses	1.39	1.71	2.13	2.04	1.95	2.17
Other Current Assets	-	0.01	0.01	0.01	0.01	0.01
Total Current Assets	14.66	19.44	17.25	27.71	20.55	41.82
Property, Plant & Equipment	0.12	0.02	-	0.05	0.09	-
Other Long-Term Assets	0.05	0.07	0.24	0.44	0.65	0.01
Total Assets	14.83	19.53	17.5	28.2	21.29	41.83

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	3.73	3.25	5.66	6.43	3.89	1.81
Accrued Expenses	3.93	4.7	8.19	9.14	9.02	7.16
Current Portion of Long-Term Debt	143.84	-	21.49	-	-	-
Current Portion of Leases	0.06	0.02	0.02	0.05	0.04	0.01
Other Current Liabilities	0.06	0.06	0.06	0.06	0.06	0.07
Total Current Liabilities	151.62	8.03	35.41	15.68	13.01	9.03
Long-Term Debt	-	137.7	85.16	72.75	39.83	29.05
Long-Term Leases	0.06	-	-	0.02	0.07	-
Other Long-Term Liabilities	-	-	-	-	0.57	1.13
Total Liabilities	151.68	145.73	120.57	88.44	53.48	39.21

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.07	0.07	0.06	0.06	0.06	0.06
Additional Paid-In Capital	307.67	304.07	296.22	291.85	275.08	271
Retained Earnings	-446.79	-432.55	-401.57	-354.37	-309.57	-270.69
Total Common Equity	-139.06	-128.41	-105.29	-62.46	-34.43	0.37
Shareholders' Equity	-136.85	-126.2	-103.07	-60.24	-32.19	2.62
Total Liabilities & Equity	14.83	19.53	17.5	28.2	21.29	41.83

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	143.96	137.72	106.66	72.81	39.93	29.06
Net Cash (Debt)	-130.69	-120	-91.54	-47.15	-21.34	10.59
Net Cash Growth	-	-	-	-	-	-60.90%
Net Cash Per Share	-2.01	-1.88	-1.47	-0.78	-0.36	0.18
Filing Date Shares Outstanding	100.85	65.83	63.18	61.9	59.44	59.36
Total Common Shares Outstanding	66.31	65.2	63.16	61.85	59.43	59.34
Working Capital	-136.96	11.41	-18.16	12.03	7.54	32.79
Book Value Per Share	-2.10	-1.97	-1.67	-1.01	-0.58	0.01
Tangible Book Value	-139.06	-128.41	-105.29	-62.46	-34.43	0.37
Tangible Book Value Per Share	-2.10	-1.97	-1.67	-1.01	-0.58	0.01
Machinery	-	0.07	0.07	0.07	0.07	0.07
Leasehold Improvements	-	0	0	0	0	0

SEC Filings: 10-K · 10-Q